Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma

Subjects were 45 patients with angioimmunoblastic T-cell lymphoma (AITL) who underwent 2-[ 18 F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) at baseline and interim after 2-4 cycles. Predictors of progression-free survival (PFS) and overall survival (OS)...

Full description

Saved in:
Bibliographic Details
Published inLeukemia & lymphoma Vol. 58; no. 6; pp. 1341 - 1348
Main Authors Moon, Seung Hwan, Lee, Ah Young, Kim, Won-Seog, Kim, Seok Jin, Cho, Young Seok, Choe, Yearn Seong, Kim, Byung-Tae, Lee, Kyung-Han
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 03.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Subjects were 45 patients with angioimmunoblastic T-cell lymphoma (AITL) who underwent 2-[ 18 F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) at baseline and interim after 2-4 cycles. Predictors of progression-free survival (PFS) and overall survival (OS) were assessed. Positive interim PET/CT (Deauville score ≥3) was a significant independent predictor of poor PFS (Hazard ratio, 4.42; p=.028), and showed marginal significance to predict OS (p=.065). Less than 60% decrease in the average change of maximum standardized uptake value normalized by lean body mass (SUL max ) also was a significant independent predictor of poor PFS (Hazard ratio, 12.96; p=.001) and poor OS (Hazard ratio, 24.11; p=.006). Interim PET/CT has a significant prognostic value for predicting PFS and OS in patients with AITL. Deauville score and percent decrease of SUL max have the potential to be useful parameter in classifying patients into good and poor responders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1042-8194
1029-2403
1029-2403
DOI:10.1080/10428194.2016.1236380